Home LiteratureArticle Details
PMID: 15690599 Published · ppublish English News

Erlotinib hydrochloride.

Nature reviews. Drug discovery ·Vol. 4 ·No. 1 ·2005-01-00 ·Pages 13-4

Dowell J, Minna JD, Kirkpatrick P

Abstract

暂无摘要

MeSH Terms
Administration, Oral Antineoplastic Agents/chemistry,pharmacology,therapeutic use Antineoplastic Combined Chemotherapy Protocols/therapeutic use Carcinoma, Non-Small-Cell Lung/drug therapy,epidemiology Clinical Trials, Phase III as Topic Docetaxel Drug Administration Schedule Drug Delivery Systems/methods,trends Drug Design Drug Screening Assays, Antitumor/methods ErbB Receptors/classification,drug effects,metabolism Erlotinib Hydrochloride Expert Testimony Humans Quinazolines/chemistry,pharmacology,therapeutic use Randomized Controlled Trials as Topic Taxoids/therapeutic use Time Factors Treatment Outcome
Chemicals
Antineoplastic Agents Quinazolines Taxoids Docetaxel Erlotinib Hydrochloride ErbB Receptors
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Dowell Jonathan
Minna John D
Kirkpatrick Peter
Article Info
Journal
Nature reviews. Drug discovery
Abbr.
Nat Rev Drug Discov
ISSN
1474-1776
Published
2005-01-00
Pages
13-4
Language
English
Region
England
NLM ID
101124171
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]